This roundtable is part of the Chatham House High-Level Series on Cancer in collaboration with Merck Sharp & Dohme Corporation (MSD). It will bring together an international and diverse group of policymakers, academics, patient groups, and the private sector to share their perspectives, debate, and discuss. The goal is to explore key policy and health system barriers to early-stage interventions.
This is an invitation only event.
Chair: Robert Yates, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House.